Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.43
Delayed Data
As of 11:22am ET
 +0.01 / +0.70%
Today’s Change
1.28
Today|||52-Week Range
4.99
-17.82%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +389.51% increase from the last price of 1.43.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$0.00
Reporting Date
Aug 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.67%
 
 
 
 
 
 
Growthannually 77.95%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.